Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria
Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare ...
Father broke down with rage when reunited with adopted 'child' accused of being an adult
The father who adopted Natalia Grace, the Ukrainian orphan who allegedly made several attempts to kill him and his wife, ...
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (March Bio), an emerging clinical stage biotechnology company committed to combating ...